Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Zynlonta led to complete remission in nearly a quarter of patients with large B-cell lymphoma.
After a median follow-up of 13 months, four of the five patients had ongoing complete remission.
After approval of the latest cellular therapy for non-Hodgkin lymphoma, the big challenge is how to extend it to common solid tumors.
Half of patients treated with Breyanzi experienced complete remission, and a majority of these responses were durable.
Here’s a list of the approved drugs to treat lyphoma including Non-Hodgkin lymphoma and Hodgkin lymphoma. Click on any of the medicat...
A former labor and delivery nurse, Lindy Sledge, 62, lives with her family in Franklin, Kentucky. She has mantle cell lymphoma.
Yescarta led to complete remission in people with advanced non-Hodgkin lymphoma.
A dedicated student of jiujitsu, Avie Barron, 36, was diagnosed with non-Hodgkin lymphoma in her right lung.
Lymphoma is a cancer that begins in the cells of the lymph system.
World Lymphoma Awareness Day (WLAD) is held on September 15 every year and is a day dedicated to raising awareness of lymphoma.
More than a third of people treated with Monjuvi plus Revlimid experienced complete remission.
Tecartus led to durable remission in a majority of participants in a Phase II study.
The popular weed killer has been linked to tens of thousands of cases of non–Hodgkin lymphoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.